Ghent University Academic Bibliography

Journal Article
A1
open access

Patterns and quality of therapeutic care for glioma : a population-based study in Belgium between 2016 and 2019

Dimitri Vanhauwaert (UGent) , K. Vanschoenbeek, G. Silvermit, A. Lombard, N. Liefhooghe, M. Lammens, F. Dedeurwaerdere, N. Whenham, C. De Gendt, Tom Boterberg (UGent) , et al.

(2026) ESMO OPEN. 11(4).

Add to list

Journal Article
A1
open access

Practical cancer nutrition, from guidelines to clinical practice : a digital solution to patient-centred care

K.S. Hustad, L.H. Koteng, A. Urrizola, J. Arends, A. Bye, O. Dajani, Luc Deliens (UGent) , M. Fallon, M.J. Hjermstad, M. Kohlen, et al.

(2025) ESMO OPEN. 10(4).

Add to list

Conference Paper
C3
open access

BIMAP : breast cancer intra-operative margin assessment using PET-CT

Anne-Sofie De Crem, Philippe Tummers (UGent) , Herman Depypere (UGent) , Geert Braems (UGent) , Rawand Salihi (UGent) , Glenn Vergauwen (UGent) , G. Cisternino, Koen Van de Vijver (UGent) , Pieter De Visschere (UGent) , Kathia De Man (UGent) , et al.

(2024) ESMO OPEN. In ESMO Open 9(Supplement 4).

Add to list

Journal Article
A1
open access

Phase I PIANO trial—PIPAC-oxaliplatin and systemic nivolumab combination for gastric cancer peritoneal metastases : clinical and translational outcomes

R. Sundar, D.K.A. Chia, J.J. Zhao, A.R.Y.B. Lee, G. Kim, H.L. Tan, A. Pang, A. Shabbir, Wouter Willaert (UGent) , H. Ma, et al.

(2024) ESMO OPEN. 9(9).

Add to list

Journal Article
A1
open access

Avelumab or talazoparib in combination with binimetinib in metastatic pancreatic ductal adenocarcinoma : dose-finding results from phase Ib of the JAVELIN PARP MEKi trial

J. Rodon Ahnert, D. S. -W Tan, I. Garrido-Laguna, W. Harb, A. Bessudo, J. T. Beck, Sylvie Rottey (UGent) , N. Bahary, N. Kotecki, Z. Zhu, et al.

(2023) ESMO OPEN. 8(4).

Add to list

Journal Article
A1
open access

Implementation of dihydropyrimidine dehydrogenase deficiency testing in Europe

M. de With, A. Sadlon, E. Cecchin, V. Haufroid, F. Thomas, M. Joerger, R.H.N. van Schaik, R.H.J. Mathijssen, C.R. Largiadèr, Kathleen Claes (UGent) , et al.

(2023) ESMO OPEN. 8(2).

Add to list

Journal Article
A1
open access

Efficacy of olaparib in advanced cancers with germline or somatic mutations in BRCA1, BRCA2, CHEK2 and ATM, a Belgian Precision tumor-agnostic phase II study

S. Joris, Hannelore Denys (UGent) , J. Collignon, M. Rasschaert, D. T’Kint de Roodenbeke, F.P. Duhoux, J.-L. Canon, S. Tejpar, J. Mebis, L. Decoster, et al.

(2023) ESMO OPEN. 8(6).

Add to list

Journal Article
A1
open access

Isatuximab plus atezolizumab in patients with advanced solid tumors : results from a phase I/II, open-label, multicenter study

M. Simonelli, E. Garralda, F. Eskens, M. Gil-Martin, C-J Yen, R. Obermannova, Y. Chao, S. Lonardi, B. Melichar, V Moreno, et al.

(2022) ESMO OPEN. 7(5).

Add to list

Journal Article
A1
open access

PRECISION : the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignment

J. Thouvenin, C. Van Marcke, L. Decoster, G. Raicevic, K. Punie, M. Vandenbulcke, R. Salgado, E. Van Valckenborgh, B. Maes, S. Joris, et al.

(2022) ESMO OPEN. 7(4).

Add to list

Journal Article
A1
open access

A randomized phase II study comparing the efficacy and safety of the glyco-optimized anti-EGFR antibody tomuzotuximab against cetuximab in patients with recurrent and/or metastatic squamous cell cancer of the head and neck : the RESGEX study

K. Klinghammer, J. Fayette, A. Kawecki, A. Dietz, P. Schafhausen, G. Folprecht, Sylvie Rottey (UGent) , P. Debourdeau, J. Lavernia, A. Jacobs, et al.

(2021) ESMO OPEN. 6(5).

Academic Bibliography

Patterns and quality of therapeutic care for glioma : a population-based study in Belgium between 2016 and 2019

Practical cancer nutrition, from guidelines to clinical practice : a digital solution to patient-centred care

BIMAP : breast cancer intra-operative margin assessment using PET-CT

Phase I PIANO trial—PIPAC-oxaliplatin and systemic nivolumab combination for gastric cancer peritoneal metastases : clinical and translational outcomes

Avelumab or talazoparib in combination with binimetinib in metastatic pancreatic ductal adenocarcinoma : dose-finding results from phase Ib of the JAVELIN PARP MEKi trial

Implementation of dihydropyrimidine dehydrogenase deficiency testing in Europe

Efficacy of olaparib in advanced cancers with germline or somatic mutations in BRCA1, BRCA2, CHEK2 and ATM, a Belgian Precision tumor-agnostic phase II study

Isatuximab plus atezolizumab in patients with advanced solid tumors : results from a phase I/II, open-label, multicenter study

PRECISION : the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignment

A randomized phase II study comparing the efficacy and safety of the glyco-optimized anti-EGFR antibody tomuzotuximab against cetuximab in patients with recurrent and/or metastatic squamous cell cancer of the head and neck : the RESGEX study

Contents

Support

Contact